feeds.benzinga.com · Dec 11, 2025
Why Did Flora Growth Corp (FLGC) Surge 6% In After-Hours Trading?
Flora Growth Corp is surging in after-hours trading following its SEC Form 1-A filing to raise up to $75 million.
FL
NASDAQ · FLGC
Flora Growth Corp.
Healthcare · Drug Manufacturers - Specialty & Generic
$7.79
Down-$3.69 (-32.14%)
Updated Aug 24, 2026, 1:56 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 5.18M
- P/E ratio
- -3.36
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 107.94K
- Avg. volume
- 49.6K
Price performance
FLGC price history
1M range · 0 trading sessions · Daily adjusted prices
FLGC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest FLGC news
The latest Smart Investors Daily articles mentioning FLGC.
Stock researchCompany · Overview
FLGC research
Overview
Company profile and research snapshot.
Company profile
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $30.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 25, 2024 | Aegis Capital | Buy | — |
| Aug 15, 2024 | Alliance Global Partners | Neutral | — |
| May 16, 2024 | Roth MKM | Buy | — |
| Apr 3, 2024 | Roth MKM | Buy | — |
| May 18, 2023 | Roth MKM | Buy | — |
News briefing
No generated briefing is available yet.
zacks.com · Nov 5, 2025
Flora Growth Corp. (FLGC) Reports Q3 Loss, Misses Revenue Estimates
Flora Growth Corp. (FLGC) came out with a quarterly loss of $4.93 per share versus the Zacks Consensus Estimate of a loss of $2.13. This compares to a loss of $9.38 per share a year ago.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
